Covidien plc (COV), Pfizer Inc. (PFE): Buybacks Could Keep Up This Stock’s Momentum

Page 1 of 2

Dublin-based pharmaceutical and medical device company Covidien plc (NYSE:COV) recently announced that it had authorized a share buyback program that could be worth up to $2 billion. This announcement comes just a few months after the company boosted its dividend by more than 15 percent and issued several quarters of solid earnings. To make matters even more interesting, the company appears to be nearing the completion of its long-awaited spin-off of Mallinckrodt Pharmaceuticals (MKG – not yet listed).

Covidien plc (COV)

Taken together, these factors appear to make a convincing case for Covidien plc (NYSE:COV)’s short-term performance. Despite exhibiting market-beating performance thus far this year, Covidien plc (NYSE:COV) is perennially overlooked in favor of larger and more “popular” medical firms like Pfizer Inc. (NYSE:PFE) and Medtronic, Inc. (NYSE:MDT) . If the company can translate these positive signs into lasting momentum for its stock, those who take long positions in Covidien plc (NYSE:COV) at these levels could be handsomely rewarded.

About Covidien

Covidien is a diversified manufacturer and distributor of various medical devices and products that can be used in institutional and private settings. It specializes in producing devices that can be used during surgery, including surgical staplers, vessel-sealing products, and laproscopic equipment for minimally invasive procedures. Covidien plc (NYSE:COV)also makes a number of tissue repair and wound care products and devices. Separately, Covidien plc (NYSE:COV) engages in a number of pharmaceutical development operations and currently spends about 4 percent of its gross revenues on research. Its signature pharmaceutical products include various pain relief drugs and imaging agents. Covidien earned $1.9 billion on gross 2012 revenues of about $12 billion.

Competitors

It goes without saying that the pharmaceutical and medical device industries are frighteningly competitive. Covidien has several major pharmaceutical competitors, including companies like Pfizer Inc. (NYSE:PFE) and Merck (MRK). Like Covidien, Pfizer Inc. (NYSE:PFE) engages in the development of a variety of pharmaceutical products. Since it focuses specifically on drugs and drug delivery systems, Pfizer Inc. (NYSE:PFE) may be better positioned to compete in this market. However, it has been widely reported that the company faces a “patent cliff” and will need to work to replenish its development pipeline. With revenues of around $59 billion, Pfizer Inc. (NYSE:PFE) is several times larger than Covidien.

Covidien also competes with medical device manufacturers like Medtronic. Many of Medtronic’s most important devices deal with various cardiovascular issues, including arrhythmia, heart failure, fibrillation and other problems. The company also produces devices that are designed to combat kidney failure and other renal issues. Medtronic is one of the world’s largest providers of musculoskeletal therapy devices and surgical aids. With revenues of around $16.5 billion, Medtronic is roughly the same size as Covidien.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

The Best Movie Sountracks Ever

The Highest Grossing Musicals on Broadway

The Most Successful Reality TV Stars

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!